Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

XPA tumor variant leads to defects in NER that sensitize cells to cisplatin

NAR Cancer(2024)10.1093/narcan/zcae013Source: DataRank Database

XPA tumor variant leads to defects in NER that sensitize cells to cisplatin is a research paper published in NAR Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

cellosaurus rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.12)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Kaitlyn Gallagher ORCID,Hyun‐Suk Kim ORCID,Mihyun Kim ORCID,Suhas S. Kharat ORCID,Christina R. Troll ORCID

Live enrichment

PubMed:38500596 PMC:PMC10946055 OpenAlex:https://openalex.org/W4393100359

NIH

Grant: F32 CA250258

NIH

Grant: P01 CA092584

NIH

Grant: R01 CA218315

NIH

Grant: T32 CA009582

Korean Institute for Basic Science

Grant: IBS-R022-A1

Vanderbilt-Ingram Cancer Center

Grant: P30CA068485

NCRR NIH HHS

Grant: S10 RR025677

NCI NIH HHS

Grant: R01 CA165911

FWCI

1.12

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: cc-by-nc

journalhttps://doi.org/10.1093/narcan/zcae013

publisherhttps://doi.org/10.1093/narcan/zcae013

publisherhttps://academic.oup.com/narcancer/article-pdf/6/1/zcae013/57138890/zcae013.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38500596

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10946055

Fields of Study

DNA Repair MechanismsGenetic factors in colorectal cancerCancer Genomics and Diagnostics

Keywords

Xeroderma pigmentosumNucleotide excision repairERCC1CisplatinDNA repairMissense mutationBiologyCancer researchDNA damageComplementationGeneMutationERCC2GeneticsDNAMolecular biologyMutantChemotherapy

Sustainable Development Goals

SDG 0: Good health and well-being